DocGo Inc DCGO.OQ DCGO.O is expected to show a fall in quarterly revenue when it reports results on February 27 for the period ending December 31 2024
The New York City-based company is expected to report a 35.0% decrease in revenue to $129.424 million from $199.25 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for DocGo Inc is for earnings of 5 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for DocGo Inc is $6.50, above its last closing price of $4.44.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
0.04
0.05
0.05
Met
2.9
Jun. 30 2024
0.06
0.08
0.07
Missed
-6.7
Mar. 31 2024
0.07
0.08
0.10
Beat
22.8
Dec. 31 2023
0.09
0.10
0.07
Missed
-30
Sep. 30 2023
0.05
0.06
0.05
Missed
-18.9
Jun. 30 2023
0.03
0.03
-0.02
Missed
-166.7
Mar. 31 2023
0.02
0.02
-0.03
Missed
-238.4
Dec. 31 2022
0.05
0.08
Beat
60
This summary was machine generated February 25 at 21:30 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)